You are here

  • Home
  • Archive
  • Volume 22, Issue Suppl 1
  • DI-010 Factors influencing the appearance of haematological and thyroid adverse effects in patients with hepatitis C virus genotype 1 treated with telaprevir/boceprevir plus peg-interferon and ribavirin

Article metrics

Article menu
Download PDFPDF
Drug information and pharmacotherapy
DI-010 Factors influencing the appearance of haematological and thyroid adverse effects in patients with hepatitis C virus genotype 1 treated with telaprevir/boceprevir plus peg-interferon and ribavirin

 

Online download statistics by month:

Online download statistics by month: March 2015 to October 2024

AbstractFullPdf
Mar 2015300
Apr 2015900
May 2015100
Jun 2015400
Jul 2015500
Aug 2015100
Sep 20151100
Oct 2015100
Nov 2015800
Dec 20151300
Jan 20161100
Feb 20161000
Mar 2016900
Apr 2016001
May 2016501
Jun 2016700
Jul 2016902
Aug 2016400
Sep 2016800
Oct 2016800
Nov 2016400
Dec 2016300
Jan 2017500
Feb 2017902
Mar 2017400
Apr 2017300
May 2017400
Jun 2017800
Jul 20172000
Aug 20172400
Sep 20173401
Oct 20172800
Nov 20172400
Dec 20173200
Jan 20183600
Feb 20183800
Mar 20185400
Apr 20183000
May 201811000
Jun 20182800
Jul 20181400
Aug 20187800
Sep 2018800
Oct 20184200
Nov 20184200
Dec 20183000
Jan 20194600
Feb 20192100
Mar 20192600
Apr 20192400
May 2019200
Jun 2019300
Jul 2019602
Aug 2019200
Sep 20192500
Nov 2019900
Dec 2019600
Jan 20201200
Feb 20201200
Mar 2020200
Apr 2020600
May 20201200
Jun 20201600
Jul 20201600
Aug 2020200
Sep 20201400
Oct 20206800
Nov 20205400
Dec 20201000
Jan 2021800
Feb 2021802
Mar 20211000
Apr 2021400
May 2021500
Jun 2021002
Oct 2021401
Nov 20212200
Dec 2021600
Jan 20221400
Feb 2022600
Mar 2022802
Apr 2022400
May 20221600
Jun 20221800
Jul 20221000
Aug 2022400
Sep 2022400
Oct 20221400
Nov 2022800
Dec 20221200
Jan 2023200
Feb 2023400
Mar 2023400
Apr 2023400
May 20231000
Jun 2023600
Jul 20231000
Aug 2023800
Sep 2023800
Oct 20231000
Nov 2023200
Dec 2023800
Jan 2024800
Feb 20241400
Mar 20241400
Apr 20241200
May 20241500
Jun 2024800
Jul 20241600
Aug 20241400
Sep 2024600
Oct 2024400
Total1605016